The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

As far as health department officials know, they plan to offer COVID vaccines again during the 2025-26 influenza and COVID season, Fedak continued. The 2024-25 COVID vaccine is available at all CVS ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Meissner was previously listed in April as a consultant to the RSV vaccines work group for the CDC committee, before Kennedy ...

Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised alarm among OB-GYNs.

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around ...

The Trump administration’s shift to narrow approval for coronavirus vaccines to only those who are at high risk for severe disease has raised concerns among Americans who came to rely on annual ...

Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around ...

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

Offit, who sits on the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made the comments after criticizing Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.

June 2, 2025 -- The FDA has approved Moderna's new COVID-19 shot, an mRNA vaccine, with some limits on who can get it. The vaccine, called mNexspike, is for people who’ve previously received a ...